Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1744234
Max Phase: Preclinical
Molecular Formula: C28H30N4O7S
Molecular Weight: 450.56
Molecule Type: Small molecule
Associated Items:
ID: ALA1744234
Max Phase: Preclinical
Molecular Formula: C28H30N4O7S
Molecular Weight: 450.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC1=Nc2ccc(N(C)Cc3ccc(S(=O)(=O)N4CCOCC4)cc3)c3cccc1c23.O=C(O)/C=C\C(=O)O
Standard InChI: InChI=1S/C24H26N4O3S.C4H4O4/c1-25-24-20-5-3-4-19-22(11-10-21(26-24)23(19)20)27(2)16-17-6-8-18(9-7-17)32(29,30)28-12-14-31-15-13-28;5-3(6)1-2-4(7)8/h3-11H,12-16H2,1-2H3,(H,25,26);1-2H,(H,5,6)(H,7,8)/b;2-1-
Standard InChI Key: OCPPSWZDJXMCEH-BTJKTKAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 450.56 | Molecular Weight (Monoisotopic): 450.1726 | AlogP: 3.11 | #Rotatable Bonds: 5 |
Polar Surface Area: 74.24 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.96 | CX LogP: 2.90 | CX LogD: 2.26 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.65 | Np Likeness Score: -1.50 |
1. Varney MD, Marzoni GP, Palmer CL, Deal JG, Webber S, Welsh KM, Bacquet RJ, Bartlett CA, Morse CA, Booth CL.. (1992) Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase., 35 (4): [PMID:1542093] [10.1021/jm00082a006] |
Source(1):